Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Inspira Technologies Oxy BHN ( (IINN) ) has provided an announcement.
On March 26, 2026, Inspira Technologies Oxy B.H.N. Ltd. announced it has established a wholly owned subsidiary as part of an internal corporate reorganization. The company plans to transfer its existing medical business activities into this new entity, signaling a move to streamline its structure and potentially enhance operational focus and regulatory alignment within its medical operations.
The formation of the subsidiary may support clearer separation of business lines and could improve flexibility for future financing, partnerships, or strategic transactions involving its medical technology portfolio. This structural shift also formalizes how Inspira’s medical activities are organized under its group, which may have implications for investors tracking the company’s operational performance and reporting going forward.
The most recent analyst rating on (IINN) stock is a Sell with a $0.68 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Neutral.
The score is held down primarily by weak financial performance—minimal/erratic revenue, negative gross profit, ongoing net losses, and significant cash burn—implying continued dependence on external funding. Technical indicators are broadly neutral, offering limited offset, while valuation metrics provide little support due to a negative P/E and no dividend yield.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. is a medical technology company based in Ra’anana, Israel, focused on developing and commercializing healthcare solutions and related medical business activities. The company operates as a foreign private issuer in the U.S. capital markets, with its securities registered with the Securities and Exchange Commission.
Average Trading Volume: 593,502
Technical Sentiment Signal: Sell
Current Market Cap: $23.15M
For detailed information about IINN stock, go to TipRanks’ Stock Analysis page.